ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION THAT HAVE ANTICANCER ACTIVITY
CY1125718T1Undetermined Publication Date: 2026-04-17CANCER RESEARCH TECHNOLOGY LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100804T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-09-29
- Filing Date
- 2022-12-21
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-12-21
Abstract
The invention provides a compound of formula (I): (I) or a tautomer, an episolvate or a salt thereof wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for the preparation of the compounds and the medical uses of the compounds.
Need to check novelty before this filing date? Find Prior Art